The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000180.4(GUCY2D):c.3G>A (p.Met1Ile)

CA226144

98603 (ClinVar)

Gene: GUCY2D
Condition: GUCY2D-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: d48d32b0-171f-48e3-a8f3-91a9f84a5d9a
Approved on: 2025-01-30
Published on: 2025-01-30

HGVS expressions

NM_000180.4:c.3G>A
NM_000180.4(GUCY2D):c.3G>A (p.Met1Ile)
NC_000017.11:g.8003050G>A
CM000679.2:g.8003050G>A
NC_000017.10:g.7906368G>A
CM000679.1:g.7906368G>A
NC_000017.9:g.7847093G>A
NG_009092.1:g.5381G>A
ENST00000254854.5:c.3G>A
ENST00000254854.4:c.3G>A
NM_000180.3:c.3G>A
More

Pathogenic

Met criteria codes 4
PP4 PVS1 PM3 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GUCY2D Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
The NM_000180.4(GUCY2D):c.3G>A variant is predicted to change the initiation codon (p.Met1) to a stop codon, with no known alternative start codons present (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_supporting). This variant has been reported in 2 unrelated probands with early-onset severe retinal dystrophy who were homozygous for the variant (0.5 points each), PMIDs: 37327959, 10951519). (1 total point, PM3). At least one proband harboring this variant exhibits a phenotype including diagnosis of LCA (0.5 pts), severe visual loss present at birth (1 pt), congenital nystagmus (1 pt), photophobia (1 pt), dyschromatopsia (1 pt), and nonrecordable ERG (0.5 pts) which together are specific for GUCY2D-related recessive retinopathy (total of 5 points, PMID: 37327959, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: PVS1, PM2_supporting, PP4, PM3. (VCEP specifications version 1.0.0; date of approval 01/22/2025).
Met criteria codes
PP4
At least one proband harboring this variant exhibits a phenotype including diagnosis of LCA (0.5 pts), severe visual loss present at birth (1 pt), congenital nystagmus (1 pt), photophobia (1 pt), dyschromatopsia (1 pt), and nonrecordable ERG (0.5 pts) which together are specific for GUCY2D-related recessive retinopathy (total of 5 points, PMID: 37327959, PP4)
PVS1
Change to initiation codon with no known alternative start codons.
PM3
This variant has been reported in 2 unrelated probands with early-onset severe retinal dystrophy who were homozygous for the variant (0.5 points each), PMIDs: 37327959, 10951519). (1 total points, PM3).
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.